VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRDF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRDFCardiff Oncology, Inc.
$0.84$65M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRDFQuarterly Financials

Cardiff Oncology, Inc. (CRDF) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Cardiff Oncology, Inc. (CRDF) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CRDF Income Statement

Quarterly statement

CRDF Income Statement

Cardiff Oncology, Inc. (CRDF) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue171K104K41K243K120K121K109K151K165K163K205K156K141K108K83K128K93K91K74K133K
Revenue Growth %42.5%-14.05%-62.39%60.93%-27.27%-25.77%-46.83%-3.21%17.02%50.93%146.99%21.88%51.61%18.68%12.16%-3.76%8.14%33.82%2.78%11.53%
Cost of Goods Sold9.39M000011.58M009.64M105K102K103K107K0000000
COGS % of Revenue5491.23%----9570.25%--5842.42%64.42%49.76%66.03%75.89%-------
Gross Profit-9.22M104K41K243K120K-11.46M109K151K-9.47M58K103K53K34K108K83K128K93K91K74K133K
Gross Margin %-5391.23%100%100%100%100%-9470.25%100%100%-5742.42%35.58%50.24%33.97%24.11%100%100%100%100%100%100%100%
Gross Profit Growth %-7782.5%100.91%-62.39%60.93%101.27%-19856.9%5.83%184.91%-27967.65%-46.3%24.1%-58.59%-63.44%18.68%12.16%-3.76%8.14%33.82%2.78%11.53%
Operating Expenses09.72M12.89M8.07M12.09M3.32M14.49M12.72M3.13M12.6M11.04M10.38M10.85M12.32M12.13M9.52M9.09M10.53M11.15M9.66M
OpEx % of Revenue-9345.19%31441.46%3320.99%10078.33%2742.15%13294.5%8425.83%1894.55%7731.9%5383.41%6657.05%7697.87%11403.7%14620.48%7437.5%9769.89%11575.82%15064.86%7262.41%
Selling, General & Admin03.8M6.13M3M3.9M04.01M3.01M03.21M3.03M2.73M2.94M4.3M3.08M3.08M3.08M3.09M3.94M3.83M
SG&A % of Revenue-3657.69%14941.46%1232.51%3247.5%-3682.57%1994.04%-1972.39%1477.07%1746.79%2084.4%3977.78%3714.46%2404.69%3308.6%3391.21%5324.32%2883.46%
Research & Development05.92M6.76M5.08M8.2M11.58M10.48M9.71M9.64M9.49M8.01M7.76M8.02M8.02M9.05M6.44M6.01M7.45M7.21M5.82M
R&D % of Revenue-5687.5%16500%2088.48%6830.83%9570.25%9611.93%6431.79%5842.42%5823.93%3906.34%4976.28%5689.36%7425.93%10906.02%5032.81%6461.29%8184.62%9740.54%4378.95%
Other Operating Expenses00000-1000K00-1000K-105K0-103K-107K0000000
Operating Income-9.22M-9.62M-12.85M-7.83M-11.97M-14.78M-14.38M-12.57M-12.6M-12.54M-10.93M-10.33M-10.82M-12.21M-12.05M-9.39M-8.99M-10.44M-11.07M-9.53M
Operating Margin %-5391.23%-9245.19%-31341.46%-3220.99%-9978.33%-12212.4%-13194.5%-8325.83%-7636.97%-7696.32%-5333.17%-6623.08%-7673.76%-11303.7%-14520.48%-7337.5%-9669.89%-11475.82%-14964.86%-7162.41%
Operating Income Growth %23.01%34.93%10.65%37.74%4.98%-17.79%-31.55%-21.68%-16.46%-2.76%9.28%-10.01%-20.32%-16.9%-8.83%1.41%-28.51%-51.59%-103.49%-46.62%
EBITDA-9.13M-9.39M-12.63M-7.6M-11.48M-14.55M-14.15M-12.48M-12.5M-12.44M-10.83M-10.23M-10.71M-12.11M-11.96M-9.31M-8.91M-10.4M-11.04M-9.41M
EBITDA Margin %-5339.77%-9031.73%-30802.44%-3129.22%-9566.67%-12023.14%-12985.32%-8262.25%-7575.76%-7631.9%-5283.41%-6557.05%-7597.87%-11212.96%-14412.05%-7270.31%-9582.8%-11434.07%-14922.97%-7077.44%
EBITDA Growth %20.46%35.43%10.77%39.05%8.16%-16.95%-30.68%-21.97%-16.68%-2.73%9.45%-9.92%-20.21%-16.39%-8.32%1.14%-29.38%-53.47%-107.46%-47.55%
D&A (Non-Cash Add-back)88K222K221K223K494K229K228K96K101K105K102K103K107K98K90K86K81K38K31K113K
EBIT-8.86M-9.23M-12.35M-7.22M-11.26M-13.94M-13.43M-11.79M-11.86M-11.78M-10.01M-9.34M-10.82M-12.21M-12.05M-9.39M-8.99M-10.44M-11.07M-8.96M
Net Interest Income363K382K506K612K716K835K941K787K741K805K926K1.01M1.07M1.05M940K740K458K253K130K79K
Interest Income363K382K506K612K716K835K941K787K741K805K926K1.01M1.07M1.05M940K740K458K253K130K79K
Interest Expense00000000000000000000
Other Income/Expense362K383K505K611K716K834K948K785K746K767K922K995K1.09M1.06M829K695K422K081K84K
Pretax Income-8.86M-9.23M-12.35M-7.22M-11.26M-13.94M-13.43M-11.79M-11.86M-11.78M-10.01M-9.34M-9.73M-11.15M-11.22M-8.7M-8.57M-10.44M-10.99M-9.44M
Pretax Margin %-5179.53%-8876.92%-30109.76%-2969.55%-9381.67%-11523.14%-12324.77%-7805.96%-7184.85%-7225.77%-4883.41%-5985.26%-6901.42%-10324.07%-13521.69%-6794.53%-9216.13%-11475.82%-14855.41%-7099.25%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-8.86M-9.23M-12.35M-7.22M-11.26M-13.94M-13.43M-11.79M-11.86M-11.78M-10.01M-9.34M-9.73M-11.15M-11.22M-8.7M-8.57M-10.44M-10.99M-9.44M
Net Margin %-5179.53%-8876.92%-30109.76%-2969.55%-9381.67%-11523.14%-12324.77%-7805.96%-7184.85%-7225.77%-4883.41%-5985.26%-6901.42%-10324.07%-13521.69%-6794.53%-9216.13%-11475.82%-14855.41%-7099.25%
Net Income Growth %21.33%33.79%8.11%38.78%5.04%-18.38%-34.19%-26.24%-21.83%-5.63%10.8%-7.36%-13.53%-6.77%-2.09%7.89%-23.98%-54.55%-112.26%-43.12%
Net Income (Continuing)-8.86M-9.23M-12.35M-7.22M-11.26M-13.94M-13.43M-11.79M-11.86M-11.78M-10.01M-9.34M-9.73M-11.15M-11.22M-8.7M-8.57M-10.44M-10.99M-9.44M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.12-0.14-0.18-0.11-0.17-0.21-0.28-0.25-0.25-0.26-0.22-0.21-0.22-0.25-0.23-0.18-0.19-0.24-0.25-0.23
EPS Growth %29.41%33.33%35.71%56%32%19.23%-27.27%-19.05%-13.64%-4%4.35%-16.67%-15.79%-4.17%8%21.74%-11.76%-41.18%-78.57%17.86%
EPS (Basic)-0.12-0.14-0.18-0.11-0.17-0.21-0.28-0.25-0.25-0.26-0.22-0.21-0.22-0.25-0.23-0.18-0.19-0.24-0.25-0.23
Diluted Shares Outstanding76.18M68.4M68.35M66.84M66.88M66.53M47.65M47.65M46.87M44.83M44.68M44.68M44.68M44.68M44.68M44.68M43.33M43.31M43.23M40.6M
Basic Shares Outstanding76.18M68.4M68.35M66.84M66.88M66.53M47.65M47.65M46.87M44.83M44.68M44.68M44.68M44.68M44.68M44.68M43.33M43.31M43.23M40.59M
Dividend Payout Ratio--------------------